This article is part of the supplement: Advances in systemic sclerosis and related fibrotic and vascular conditions
Therapeutic targets in systemic sclerosis
-
Correspondence: Christopher P Denton c.denton@medsch.ucl.ac.uk
Arthritis Research & Therapy 2007, 9(Suppl 2):S6 doi:10.1186/ar2190